Huajian Medical Holdings Limited was incorporated under Cayman Islands law on January 15, 2016. Its main business is investment holding. The Group has three subsidiaries in Hong Kong, China: Weishida Medical Co., Ltd., China Testing International Co., Ltd., and Avid (China) Co., Ltd. Each of the three subsidiaries has subsidiaries or branches in mainland China and offices in major cities across the country. The company has nearly 550 employees and is mainly engaged in the development, production and sale of medical instruments and consumables for in vitro diagnosis. Its business covers mainland China and Hong Kong. Since the establishment of Weishida Medical Co., Ltd. in 1993, we have focused on in vitro diagnosis business. After more than 20 years of development, we have now become the leading company specializing in in in vitro diagnosis business in China, providing value-added products and services to the Chinese laboratory industry.
No Data
No Data